Patents (1374 Stem Cell Patents)

Class: Use (255)

Order by:
<< | < | 6 7 8 9 10 11 12 13 14 | > | >>


Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells

Patent Number: 7,399,751

This is a patent with priority in 1999 describing the use of genetically modified Sertoli cells for immune protection of implanted cells AND the use of the Sertoli cells themselves as the vector...genetic engineer with any gene is covered.

This patent is part of the Canadian company Sernova's (CDNX:SVA.V) potent intellectual property...

Inventors: Kirkpatrick; Shaun A. (Tucson, AZ), Gores; Paul (Charlotte, NC), Halberstadt; Craig (Charlotte, NC)
Assignee: Sertoli Technologies, Inc. (Tucson, AZ)
Date of First Priority Issue: Thursday November 4th, 1999

Method of preparing suppressor T cells with allogeneic mesenchymal stem cells

Patent Number: 6281012

This patent covers the use of mesenchymal stem cells to generate T suppressor cells in general. Specifically it mentions that CD8 positive T cells can be turned into suppressor cells by contact with mesenchymal stem cells. Usually, T suppressor cells are called T regulatory cells and this refers to CD4+ CD25Inventors: McIntosh, Kevin (Ellicott City, MD); Klyushnenkova, Elena (Baltimore, MD)

Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Date of First Priority Issue: Tuesday October 12th, 1999

Method for in vivo ex vivo and in vitro repair and regeneration of cartilage and collagen and bone remodeling

Patent Number: 6528052

This patent discloses frequencies and methods of culturing stem cells in order to generate a source of bioartificial cartilage.

Inventors: Smith, R. Lane (Palo Alto, CA); Carter, Dennis R. (Stanford, CA); Schurman, David J. (Stanford, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University (Stanford, CA)
Date of First Priority Issue: Friday October 1st, 1999

Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof

Patent Number: 7078232

Repair of articular cartilage is a substantial problem. The patent is useful for entities interested in providing a solution to this problem through the administration of cellular therapy containing adipose-derived stem cells in a biocompatible matrix or delivery system. The patent specifically has 4 independent claims. The first claim covers a composition of matter that is useful for...

Inventors: Konkle, Jon (Durham, NC); Gimble, Jeffrey M. (Baton Rouge, LA)
Assignee: Artecel, Inc.
Date of First Priority Issue: Thursday August 19th, 1999

Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair

Patent Number: 7033587

This patent teaches ways to make artificial cartilage patches using adipose stem cells as starting material. These patches may be useful for people having injuries in which cartilage is damaged. The patent has 1 independent claim which essentially covers producing such an artifical patch through taking out adipose stem cells, culturing the cells to become chondrocytes, allowing the...

Inventors: Halvorsen, Yuan-Di C. (Holly Springs, NC); Wilkison, William O. (Bahama, NC); Gimble, Jeffrey Martin (Chapel Hill, NC)
Assignee: Artecel Sciences, Inc. (Durham, NC)
Date of First Priority Issue: Thursday August 19th, 1999

Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair

Patent Number: 6841150

This appears to be a very important patent in that it teaches the use of adipose stem cells for generating chondrocytes and using the chondrocytes to heal cartilage. This patent should be compared to ones by Osiris that use adipose derived mesenchymal stem cells for cartilage repair, as well as by Cytori which uses adipose derived stem cells for a variety of indications.

Inventors: Halvorsen, Yuan-Di C. (Holly Springs, NC); Wilkison, William O. (Bahama, NC); Gimble, Jeffrey Martin (Chapel Hill, NC)
Assignee: Artecal, Sciences, Inc. (Durham, NC)
Date of First Priority Issue: Thursday August 19th, 1999

Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair

Patent Number: 6429013

This patent teaches how to generate cartilage and chondrocytes from stromal cells that are derived from adipose tissues. Another company working heavily in this area is Cytori, formerly called Macropore.

Inventors: Halvorsen, Yuan-Di C. (Holly Springs, NC); Wilkison, William O. (Bahama, NC); Gimble, Jeffrey Martin (Chapel Hill, NC)
Assignee: Artecel Science, Inc. (Durham, NC)
Date of First Priority Issue: Thursday August 19th, 1999

Treatment of liver disease and injury with CXC chemokines

Patent Number: 6719969

This patent teaches that CXC chemokines are potent stimulators of hepatic stem cells and hepatic regeneration. Chemokines covered include MIP-2, ENA-78 and IL-8.

Inventors: Hogaboam, Cory M. (Ann Arbor, MI); Bone-Larson, Cynthia L. (Petersburg, MI); Simpson, Kenneth J. (Edinburgh, GB); Lukacs, Nicholas W. (Brighton, MI); Kunkel, Steven L. (Ann Arbor, MI); Colletti, Lisa M. (Webberville, MI); Strieter, Robert M. (Sherman Oaks
Assignee: The Regents of The University of Michigan (Ann Arbor, MI) University Court of The University of Edinburgh (GB)
Date of First Priority Issue: Monday August 9th, 1999 2 Comments

Muscle cells and their use in cardiac repair

Patent Number: 6673604

This is a composition patent covering myocardial and fibroblast cell preparations that are useful for administration in the post-infarct myocardium. This approach is interesting and a similar approach seems to have been used clinically by the company Bioheart.

Inventor: Edge, Albert (Cambridge, MA)
Assignee: Diacrin, Inc. (Charlestown, MA)
Date of First Priority Issue: Friday July 23rd, 1999

Ischemia detection system

Patent Number: 6277082

This patent provides a medical device that detects ischemia based on electrical conductivity and other parameters. This invention is useful in combination with stem cell therapy so as to enable the administrator of stem cell angiogenic therapy to decide when and where therapy is needed.

Inventor: Gambale, Richard A. (Tyngsboro, MA)
Assignee: C. R. Bard, Inc. (Murray Hill, NJ)
Date of First Priority Issue: Thursday July 22nd, 1999

Order by:
<< | < | 6 7 8 9 10 11 12 13 14 | > | >>





Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2009 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03